🇺🇸 Enalapril/hydrochlorothiazide in United States

406 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 406

Most-reported reactions

1. Drug Interaction — 76 reports (18.72%)
2. Acute Kidney Injury — 47 reports (11.58%)
3. Headache — 41 reports (10.1%)
4. Hyponatraemia — 41 reports (10.1%)
5. Dizziness — 40 reports (9.85%)
6. Drug Ineffective — 38 reports (9.36%)
7. Insomnia — 36 reports (8.87%)
8. Fatigue — 32 reports (7.88%)
9. Somnolence — 28 reports (6.9%)
10. Malaise — 27 reports (6.65%)

Source database →

Frequently asked questions

Is Enalapril/hydrochlorothiazide approved in United States?

Enalapril/hydrochlorothiazide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Enalapril/hydrochlorothiazide in United States?

Erasmus Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.